文献速递血液净化与透析

低温血液透析对普通血液透析人群透析中低血压预防效果及死亡率的影响

Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

在8071例新发血液透析患者队列中,27%的患者系统接受透析液温度≤35.5°C的治疗。中位随访13.6个月,透析液温度每降低0.5°C与透析中低血压风险小幅降低相关(OR 0.976),在机构层面病例组合调整后关联更强(OR 0.67,风险降低33%),但低温透析与全因死亡率无关联。

要点

  • 透析液温度每降低0.5°C,透析中低血压风险OR为0.976(95%CI 0.957-0.995,P=.013)。
  • 机构层面病例组合调整后,OR为0.67(95%CI 0.63-0.72,风险降低33%,P<.001)。
  • 低温透析与全因死亡率无关联,未调整HR 1.074(95%CI 0.972-1.187,P=.16)。

核心结论

  • 低温血液透析与血液透析人群透析中低血压相关,但与全因死亡率无关联。

研究设计与样本

  • 研究为针对新发血液透析患者(n=8071)的队列研究,采用广义估计方程模型分析透析液温度与透析中低血压(最低血压<90 mmHg)的关系,采用Cox回归分析全因死亡率,并应用工具变量在机构层面调整病例组合以控制适应证偏倚等混杂因素。

主要发现

  • 研究队列中27%的患者系统接受透析液温度≤35.5°C的治疗。
  • 中位随访13.6个月(四分位距5.2-26.1个月),透析液温度每降低0.5°C与透析中低血压风险小幅降低相关(OR 0.976,95%CI 0.957-0.995,P=.013)。
  • 在机构层面病例组合调整分析中,关联变得更强(OR 0.67,95%CI 0.63-0.72,风险降低33%,P<.001)。
  • 低温透析液与死亡率无关联,未调整分析HR(每降低0.5°C)1.074(95%CI 0.972-1.187,P=.16),机构层面病例组合调整分析HR 1.01(95%CI 0.88-1.16,P=.84)。
  • 应用透析液中位温度或机构中透析液温度<36°C处方患者百分比作为工具变量的额外分析,以及仅限于反复发生透析中低血压患者的进一步分析,均完全证实上述结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cold hemodialysis (HD) prevented intradialysis hypotension (IDH) in small, short-term, randomized trials in selected patients with IDH. Whether this treatments prevents IDH and mortality in the HD population at large is unknown. METHODS: We investigated the relationship between dialysate temperature and the risk of IDH, i.e. nadir blood pressure <90 mmHg (generalized estimating equation model) and all-cause mortality (Cox's regression) in an incident cohort of HD patients (n = 8071). To control for confounding by bias by indication and other factors we applied instrumental variables adjusting for case mix at facility level. RESULTS: Twenty-seven percent of patients in the study cohort were systematically treated with a dialysate temperature ≤35.5°C. Over a median follow-up of 13.6 months (interquartile range 5.2-26.1 months), a 0.5°C reduction of the dialysate temperature was associated with a small (-2.4%) reduction of the risk of IDH [odds ratio (OR) 0.976, 95% confidence interval (CI) 0.957-0.995, P = .013]. In case-mix, facility-level adjusted analysis, the association became much stronger (OR 0.67, 95% CI 0.63-0.72, risk reduction = 33%, P < .001). In contrast, colder dialysate temperature had no effect on mortality both in the unadjusted [hazard ratio (HR) (0.5°C decrease) 1.074, 95% CI 0.972-1.187, P = .16] and case-mix-adjusted analysis at facility level (HR 1.01, 95% CI 0.88-1.16, P = .84). Similar results were registered in additional analyses by instrumental variables applying the median dialysate temperature or the facility percentage of patients prescribed a dialysate temperature <36°C. Further analyses restricted to patients with recurrent IDH fully confirmed these findings. CONCLUSIONS: Cold HD was associated with IDH in the HD population but had no association with all-cause mortality.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Zoccali C, Tripepi G, Neri L, et al. Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population. Nephrol Dial Transplant. 2023. PMID: 36649682. doi:10.1093/ndt/gfad003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。